Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
1.
Reprod Biomed Online ; 44(2): 271-279, 2022 02.
Artigo em Inglês | MEDLINE | ID: mdl-35031239

RESUMO

RESEARCH QUESTION: Is the efficacy of imported vitrified oocyte donation affected by the cryobank of origin? DESIGN: Longitudinal cohort study, including 249 completed oocyte warming cycles from 200 recipients (January 2016-July 2020). No severe male factor was included. Vitrified oocytes were provided by three Spanish cryobanks. Primary outcome was cumulative live birth delivery rate (CLBR) per completed oocyte warming cycle. RESULTS: After warming 1535 oocytes, 1244 survived (81.0%) and 945 fertilized (76.0%); embryo utilization rate was 65.3%. The overall CLBR per completed cycle was 47.0% but was lower in cryobank 1 (31.2%) versus cryobank 2 (56.0%, P = 0.0010) and cryobank 3 (50.8%, P = 0.0241). Multivariate logistic regression analysis identified survival of four or more oocytes as the strongest predictor for delivery (P = 0.0282). Only 202 out of 249 oocyte warming cycles had four or more survived oocytes in a proportion that was significantly lower in cryobank 1 versus cryobank 2 (70.1% versus 89.0%, P = 0.0020); comparison with cryobank 3 (81.0%) was not significant. In the 202 oocyte warming cycles, CLBR in cryobank 1 (37.0%) was lower versus cryobank 2 (58.8%, P = 0.0115) and cryobank 3 (60.8%, P = 0.0019), suggesting a reduced viability in oocytes from cryobank 1 that survived warming. CONCLUSIONS: Differences were found in the efficacy of imported vitrified oocytes in relation to the cryobank of origin. Each centre needs to evaluate the results internally when starting a collaboration with an oocyte cryobank to establish the necessary measures to maximize treatment efficacy.


Assuntos
Fertilização in vitro , Doação de Oócitos , Coeficiente de Natalidade , Criopreservação/métodos , Feminino , Humanos , Estudos Longitudinais , Masculino , Oócitos , Gravidez , Taxa de Gravidez , Estudos Retrospectivos
2.
Reprod Biomed Online ; 41(6): 1055-1069, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-33032906

RESUMO

RESEARCH QUESTION: What is the proportion of chromosomally abnormal spermatozoa in men with a history of reproductive failure, including patients with normal karyotype and carriers of translocations? Should this analysis be included in a clinical setting to define the best treatment options for infertile couples? DESIGN: Aneuploidy for chromosomes XY, 13, 15, 16, 17, 18, 21, 22 was tested by fluorescent in-situ hybridization (FISH) in 1665 samples from couples with normal karyotype having had at least three previous IVF failures, miscarriages, or both (group-A). A FISH test was also carried out in 76 samples from carriers of translocations (group B) to detect the proportion of spermatozoa with unbalanced rearrangement. RESULTS: In group A, the lowest incidence of aneuploid sperm cells was found in men with normozoospermia (1.3%, range 0.09-6.31%) compared with men with moderate oligoasthenoteratozoospermia (2.1%, range 0.41-16.6%, P < 0.001), severe oligoasthenoteratozoospermia (4.7%, range 0.53-30.77, P < 0.001), microepididymal sperm aspiration (3.1%, range 1.19-24.24, P < 0.001) and testicular sperm extraction samples (5.8%, range 1.54-33.3, P < 0.001). In group B, the proportion of spermatozoa with unbalanced rearrangement was significantly higher in reciprocal (63%, range 10.0-87.6%) than in Robertsonian translocations (16%, range 4.3-51.0%, P < 0.001). CONCLUSIONS: Patients with poor prognosis of term pregnancy tend to generate high proportions of chromosomally abnormal spermatozoa, especially in severe male factor cases. Corresponding frequencies occur at wide ranges; therefore, the FISH test is needed to assess the proportion of spermatozoa with altered chromosome condition. A flowchart, which included the FISH test, was designed to assist clinicians guide couples with poor prognosis of pregnancy, on the most indicated treatment options.


Assuntos
Aberrações Cromossômicas , Infertilidade Masculina/genética , Espermatozoides/metabolismo , Adulto , Aneuploidia , Heterozigoto , Humanos , Hibridização in Situ Fluorescente , Infertilidade Masculina/diagnóstico , Infertilidade Masculina/patologia , Cariotipagem , Masculino , Prognóstico , Técnicas de Reprodução Assistida , Análise do Sêmen , Espermatozoides/patologia , Translocação Genética
3.
Fertil Steril ; 109(4): 644-664, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29653717

RESUMO

OBJECTIVE: To assess the role of recombinant human LH (r-hLH) supplementation in ovarian stimulation for ART in specific subgroups of patients. DESIGN: Systematic review. SETTING: Centers for reproductive care. PATIENT(S): Six populations were investigated: 1) women with a hyporesponse to recombinant human FSH (r-hFSH) monotherapy; 2) women at an advanced reproductive age; 3) women cotreated with the use of a GnRH antagonist; 4) women with profoundly suppressed LH levels after the administration of GnRH agonists; 5) normoresponder women to prevent ovarian hyperstimulation syndrome; and 6) women with a "poor response" to ovarian stimulation, including those who met the European Society for Human Reproduction and Embryology Bologna criteria. INTERVENTION(S): Systematic review. MAIN OUTCOME MEASURE(S): Implantation rate, number of oocytes retrieved, live birth rate, ongoing pregnancy rate, fertilization rate, and number of metaphase II oocytes. RESULT(S): Recombinant hLH supplementation appears to be beneficial in two subgroups of patients: 1) women with adequate prestimulation ovarian reserve parameters and an unexpected hyporesponse to r-hFSH monotherapy; and 2) women 36-39 years of age. Indeed, there is no evidence that r-hLH is beneficial in young (<35 y) normoresponders cotreated with the use of a GnRH antagonist. The use of r-hLH supplementation in women with suppressed endogenous LH levels caused by GnRH analogues and in poor responders remains controversial, whereas the use of r-hLH supplementation to prevent the development of ovarian hyperstimulation syndrome warrants further investigation. CONCLUSION(S): Recombinant hLH can be proposed for hyporesponders and women 36-39 years of age.


Assuntos
Fármacos para a Fertilidade Feminina/administração & dosagem , Infertilidade/terapia , Hormônio Luteinizante/administração & dosagem , Indução da Ovulação/métodos , Ovulação/efeitos dos fármacos , Adulto , Transferência Embrionária , Feminino , Fármacos para a Fertilidade Feminina/efeitos adversos , Fertilização in vitro , Humanos , Infertilidade/diagnóstico , Infertilidade/fisiopatologia , Nascido Vivo , Hormônio Luteinizante/efeitos adversos , Pessoa de Meia-Idade , Recuperação de Oócitos , Indução da Ovulação/efeitos adversos , Gravidez , Taxa de Gravidez , Proteínas Recombinantes/administração & dosagem , Fatores de Risco , Resultado do Tratamento
5.
Reprod Biomed Online ; 34(2): 162-165, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27825533

RESUMO

This is a pilot study performed in a private IVF unit. The objective of the study was to investigate whether luteal support is required in IVF cycles after mild stimulation with clomiphene citrate and low FSH doses. The study included 15 patients with good prognosis (defined as ≤38 years old with normal ovarian reserve and normovulatory cycles, body mass index <29 kg/m2, no previous cycles, no severe endometriosis, no history of recurrent miscarriage, no endocrine/autoimmune diseases and no surgical semen extraction from the partner) undergoing IVF with mild stimulation. Patients were monitored during the luteal phase by serum progesterone and LH. The luteal support was started only when necessary. No patient needed luteal phase support because the resultant steroid environment was different from that associated with conventional stimulation techniques. The live birth rate was 40% (6/15) and the implantation rate 30% (6/20). There are several benefits to mild stimulation, including low cost, less patient distress and improved endometrial receptivity. Our study supports the concept that mild stimulation may have an additional benefit during the luteal phase, by obviating the need for luteal phase support.


Assuntos
Implantação do Embrião , Fertilização in vitro , Fase Luteal/fisiologia , Indução da Ovulação , Adulto , Índice de Massa Corporal , Clomifeno/administração & dosagem , Feminino , Fertilidade , Fármacos para a Fertilidade Feminina/administração & dosagem , Hormônio Foliculoestimulante/administração & dosagem , Hormônio Liberador de Gonadotropina/antagonistas & inibidores , Humanos , Hormônio Luteinizante/sangue , Reserva Ovariana , Indução da Ovulação/métodos , Projetos Piloto , Gravidez , Taxa de Gravidez , Progesterona/sangue , Prognóstico
6.
Eur J Obstet Gynecol Reprod Biol ; 207: 211-213, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27832922

RESUMO

Infertility is a condition affecting an increasing number of individuals all over the world. In recent years, this phenomenon has spread across both western countries and developing countries, thus developing the features of a pandemic. For this reason, the World Health Organization (WHO) acknowledged that infertility should be considered a disease to all intents and purposes, as it diminishes the health and wellbeing of the individuals who suffers from it. At present, the most effective means to contain the spread of infertility are essentially prevention and Assisted Reproductive Technologies (ART). With reference to the latter, although most of these techniques are routinely used in the majority of countries, they are still subject to medical, ethical and political debates. There are huge variations noted when the regulatory legislation adopted by different countries to govern infertility treatment in various countries all over the world are reviewed. In fact, it has to be recognized that ART legislation depends on a variety of factors, such as social structure, political choices, ethical issues and religious beliefs. This makes it apparently impossible to create a standard regulation for different countries, especially in case of controversial issues like gamete and embryo donation, embryo cryopreservation or surrogacy.


Assuntos
Infertilidade Feminina/terapia , Infertilidade Masculina/terapia , Técnicas de Reprodução Assistida , Adulto , Criopreservação/ética , Ectogênese/ética , Transferência Embrionária/efeitos adversos , Transferência Embrionária/ética , Embrião de Mamíferos , Europa (Continente) , Feminino , Conhecimentos, Atitudes e Prática em Saúde , Acessibilidade aos Serviços de Saúde/ética , Acessibilidade aos Serviços de Saúde/legislação & jurisprudência , Transição Epidemiológica , Humanos , Legislação Médica , Masculino , Gravidez , Religião , Direitos Sexuais e Reprodutivos/educação , Direitos Sexuais e Reprodutivos/legislação & jurisprudência , Técnicas de Reprodução Assistida/efeitos adversos , Técnicas de Reprodução Assistida/ética , Técnicas de Reprodução Assistida/legislação & jurisprudência , Técnicas de Reprodução Assistida/normas , Mães Substitutas , Obtenção de Tecidos e Órgãos/ética , Obtenção de Tecidos e Órgãos/legislação & jurisprudência , Organização Mundial da Saúde
7.
Gynecol Endocrinol ; 32(1): 1-5, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26531067

RESUMO

Ovarian reserve markers have been documented to perform very well in the clinical practice. While this is widely recognized, still now there is no consensus on how to use new biomarkers in the clinical practice. This study was conducted among Italian IVF centres using the Delphi technique, a validated consensus-building process. Briefly three consecutive questionnaires were developed for clinicians in charge of IVF centres. In the first rounds, participants were asked to rate the importance of a list of statements regarding the categorization of ovarian response and the diagnostic role of biomarkers. In round 3, participants were asked to rate their agreement and consensus on the list of statements derived from the first two rounds. There were 120 respondents. Consensus was achieved for many points: (a) poor ovarian response is predicted on the basis of the following: AMH < 1 ng/ml or AFC < 7, FSH ≥ 10 IU/l, age ≥ 40 yrs; (b) hyper-response is predicted on the basis of the following: AMH > 3 ng/ml or AFC > 14; (c) day 3 FSH measurement should always be associated to estradiol; (d) AMH can be measured on a random basis; (e) the measurement of the AFC with the 2D technology may be considered adequate and (f) the AFC should be measured in the early follicular phase and consists in the total number of 2-9 mm follicles in both the ovaries. The present study suggests that extensive consensus on the importance and use of new ovarian reserve markers to improve IVF safety and performance is already present among clinicians.


Assuntos
Hormônio Antimülleriano/sangue , Fertilização in vitro/métodos , Hormônio Foliculoestimulante/sangue , Folículo Ovariano/diagnóstico por imagem , Síndrome de Hiperestimulação Ovariana/sangue , Reserva Ovariana , Indução da Ovulação/métodos , Fatores Etários , Biomarcadores , Técnica Delphi , Estradiol/sangue , Feminino , Fase Folicular/sangue , Humanos , Itália , Medição de Risco , Inquéritos e Questionários
8.
Fertil Steril ; 104(2): 333-8, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26051093

RESUMO

OBJECTIVE: To validate the use of clomiphene citrate in IVF when mild stimulation approaches are chosen to reduce patient discomfort, risk, and cost. DESIGN: Prospective cohort study. SETTING: Private IVF clinic. PATIENT(S): A total of 163 patients undergoing IVF and with a good prognosis (defined as ≤38 years old with normal ovarian reserve and normovulatory cycles, body mass index <29 kg/m(2), no previous assisted reproductive technology cycles, no severe endometriosis, no history of recurrent miscarriage, no endocrine/autoimmune diseases, and no surgical semen extraction). INTERVENTION(S): Mild stimulation using a fixed protocol of clomiphene citrate (100 mg/d from cycle days 3 to 7) in combination with low doses of gonadotropins (150 IU of recombinant FSH on cycle days 5, 7, and 9) and GnRH antagonist. MAIN OUTCOME MEASURE(S): The cumulative delivery rate per patient after three fresh and/or frozen embryo transfers and time to pregnancy. RESULT(S): No dropouts were observed. The cumulative delivery rate was 70%, and the mean time to pregnancy was 2.4 months. CONCLUSION(S): Mild stimulation using clomiphene citrate in combination with low doses of gonadotropins can be considered a realistic option for good-prognosis patients undergoing IVF.


Assuntos
Clomifeno/administração & dosagem , Fármacos para a Fertilidade Feminina/administração & dosagem , Fertilização in vitro/métodos , Indução da Ovulação/métodos , Adulto , Estudos de Coortes , Feminino , Humanos , Masculino , Gravidez , Taxa de Gravidez/tendências , Estudos Prospectivos
9.
Mol Hum Reprod ; 21(1): 46-57, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25301778

RESUMO

To investigate the mitochondrial DNA (mtDNA) segregation in human oocytes, the level of heteroplasmy in the three products of meioses, polar bodies (PBs) and corresponding oocytes, was assessed by studying the hypervariable region I (HVRI) of the D-loop region. The DNA from 122 PBs and 51 oocytes from 16 patients was amplified by whole genome amplification (WGA). An aliquot of the WGA product was used to assess aneuploidy, and another aliquot to study mtDNA. The HVRI was amplified and sequenced with an efficiency of 75.4 and 63%, respectively, in PBs, and of 100% in oocytes. The comparison with the mtDNA sequences from blood of the individual donors showed full correspondence of polymorphisms with the matching oocytes, whilst in PBs the degree of concordance dropped to 89.6%. Haplogroups were inferred for all 16 patients. Of the 89 diagnosed PBs from the 13 patients belonging to macrohaplogroup R, 23 were euploid and 66 aneuploid. The incidence of total anomalies was significantly lower in haplogroup H (6.5%) when compared with haplogroups J and T (17.6 and 13.4% respectively; P < 0.001). In haplogroup J, hypoaneuploidy occurred more frequently than hyperaneuploidy. In the three patients belonging to haplogroup N*, 81% of PBs were aneuploid with similar rates of chromosome hypoaneuploidy and hyperaneuploidy. The presence of mtDNA base changes confined to PBs could reflect a selection mechanism against severe mtDNA mutations, while permitting a high evolution rate that could result in bioenergetic diversity. The different susceptibility to aneuploidy by some haplogroups strongly supports this hypothesis.


Assuntos
DNA Mitocondrial/análise , Oócitos/metabolismo , Corpos Polares/metabolismo , Adulto , Cromossomos , Feminino , Humanos , Infertilidade Feminina/genética , Infertilidade Feminina/metabolismo
10.
Biomed Res Int ; 2014: 926172, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25197669

RESUMO

INTRODUCTION: Poor response to ovarian stimulation is still a major problem in IVF. The study presents a new stimulation protocol evaluated in a suppopulation of very difficult young poor ovarian responders. MATERIAL AND METHODS: The study consists in two sections. The first includes data from a randomized controlled study involving forty-three young patients with a poor ovarian response in at least two previous cycles (intended as cycle cancellation or with ≤3 collected oocytes). Patients were randomized in two groups: group A (control) received FSH (400 IU/day), while group B received the new stimulation protocol consisting in a sequential association of 150 IU r-LH for 4 days followed by 400 IU r-FSH/after downregulation with daily GnRh agonist. The second includes data from the overall results in 65 patients treated with the new protocol compared to their previous performance with conventional cycles (historical control). RESULTS: Both in the RCT and in the historical control study, LH pretreatment was able to decrease the cancellation rate, to improve the in vitro performance, and to significantly increase the live birth rates. CONCLUSIONS: LH pretreatment improved oocyte quantity and quality in young repeated poor responders selected in accordance with the Bologna criteria.


Assuntos
Fertilização in vitro , Hormônio Luteinizante/farmacologia , Adulto , Feminino , Hormônio Foliculoestimulante/farmacologia , Humanos , Ovário/efeitos dos fármacos , Indução da Ovulação , Resultado do Tratamento
11.
PLoS One ; 9(7): e102182, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25032828

RESUMO

The objective of the present study was to develop an approach that could assess the chromosomal status and the mitochondrial DNA (mtDNA) content of oocytes and their corresponding polar bodies (PBs) with the goal of obtaining a comparative picture of the segregation process both for nuclear and mtDNA. After Whole Genome Amplification (WGA), sequencing of the whole mitochondrial genome was attempted to analyze the segregation of mutant and wild-type mtDNA during human meiosis. Three triads, composed of oocyte and corresponding PBs, were analyzed and their chromosome status was successfully assessed. The complete mitochondrial genome (mitogenome) was almost entirely sequenced in the oocytes (95.99% compared to 98.43% in blood), while the percentage of sequences obtained in the corresponding PB1 and PB2 was lower (69.70% and 69.04% respectively). The comparison with the mtDNA sequence in blood revealed no changes in the D-loop region for any of the cells of each triad. In the coding region of blood mtDNA and oocyte mtDNA sequences showed full correspondence, whereas all PBs had at least one change with respect to the blood-oocyte pairs. In all, 9 changes were found, either in PB1 or PB2: 4 in MT-ND5, 2 in MT-RNR2, and 1 each in MT-ATP8, MT-ND4, MT-CYTB. The full concordance between oocyte and blood in the 3 triads, and the relegation of changes to PBs, revealed the unexpected coexistence of different variants, giving a refined estimation of mitochondrial heteroplasmy. Should these findings be confirmed by additional data, an active mechanism could be postulated in the oocyte to preserve a condition of 'normality'.


Assuntos
Cromossomos/genética , DNA Mitocondrial/genética , Genoma Mitocondrial/genética , Oócitos/citologia , Corpos Polares/citologia , Sequência de Bases , Segregação de Cromossomos/genética , Feminino , Variação Genética , Humanos , Meiose/genética , Mitocôndrias/genética , Dados de Sequência Molecular , Análise de Sequência de DNA
12.
Hum Reprod ; 29(9): 1842-5, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-25008235

RESUMO

The Bologna criteria were published by the European Society of Human Reproduction and Embryology (ESHRE) in 2011 to help address the lack of a clear definition of poor ovarian responders. Since its publication, aspects of the criteria have been cited several times, whilst others have been criticized. In this debate, we re-examine the criteria (which address age, the number of oocytes retrieved and the results of ovarian reserve tests) following new evidence produced and we analyse the criticism received in an attempt to determine if revisions are needed.


Assuntos
Fertilização in vitro/métodos , Indução da Ovulação/métodos , Ensaios Clínicos Controlados Aleatórios como Assunto , Projetos de Pesquisa , Feminino , Humanos , Infertilidade/terapia , Seleção de Pacientes , Resultado do Tratamento
14.
Reprod Biomed Online ; 28(1): 125-32, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24268726

RESUMO

National legislations represent one of the main factors influencing access to assisted reproduction treatment. The Italian situation in the last decade is an example of how the treatment of patients for preimplantation genetic diagnosis (PGD) was more dependent on regulators than on medical choices. This report analysed how the changes in Italian regulation affected the number of PGD referrals to this study centre, as well as their decision to opt for cross-border reproductive care (CBRC). The analysis showed that during the period in which PGD was actually not performed because of the restriction imposed by the Italian law on IVF (from 24 February 2004 to 7 May 2009) there was a significant decrease in the number of referrals asking for PGD (2.5% of total referrals) compared with the previous years (3.3%; P < 0.025) and following years when PGD was legalized (5.1%; P < 0.001). The number of couples opting for CBRC had an opposite trend, reaching a maximum when PGD was banned from Italian centres (55 couples), whereas after the readmission of PGD, only eight couples went abroad for treatment. Concomitantly, since May 2009, the proportion of couples performing a PGD cycle in this centre has constantly increased.


Assuntos
Fertilização in vitro/legislação & jurisprudência , Doenças Genéticas Inatas/diagnóstico , Doenças Genéticas Inatas/epidemiologia , Turismo Médico/estatística & dados numéricos , Diagnóstico Pré-Implantação/estatística & dados numéricos , Feminino , Fertilização in vitro/estatística & dados numéricos , Doenças Genéticas Inatas/prevenção & controle , Humanos , Itália/epidemiologia , Turismo Médico/legislação & jurisprudência , Turismo Médico/tendências , Gravidez , Encaminhamento e Consulta/estatística & dados numéricos
15.
Asian J Androl ; 14(4): 591-8, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22543677

RESUMO

The objective of this study was to investigate whether medical therapy can reduce sperm aneuploidy levels and improve the results of intracytoplasmic sperm injection (ICSI) in patients with severe idiopathic oligoasthenoteratospermia (OAT). Thirty-three infertile couples requiring ICSI because of severe idiopathic OAT after at least one unsuccessful ICSI cycle were considered. Semen parameters (concentration, motility and morphology), the percentage of aneuploid sperm and the results of ICSI (the number of oocytes fertilized, embryos transferred, biochemical pregnancies, clinical pregnancies and live births) were compared before and after a 3-month course of treatment with L-carnitine 1 g given twice per day+acetyl-L-carnitine 500 mg given twice per day+one 30-mg cinnoxicam tablet every 4 days. Aneuploidy was assessed using fluorescent in situ hybridisation (FISH) performed on chromosomes X, Y, 13, 15, 16, 17, 18, 21 and 22. The results showed that 22 of the 33 patients had a reduced frequency of aneuploid sperm and improved sperm morphology after treatment (group 1), and 11 showed no change (group 2). The numbers of biochemical pregnancies, clinical pregnancies and live births were significantly higher in group 1 than in group 2. No significant difference was found between the groups regarding the numbers of oocytes fertilized and embryos transferred. The side effects were negligible. The numbers of ICSI pregnancies and live births in severe idiopathic OAT patients improved with a course of L-carnitine, acetyl-L-carnitine and cinnoxicam.


Assuntos
Aneuploidia , Astenozoospermia/tratamento farmacológico , Infertilidade Masculina/tratamento farmacológico , Oligospermia/tratamento farmacológico , Espermatozoides/citologia , Espermatozoides/efeitos dos fármacos , Adulto , Carnitina/uso terapêutico , Distribuição de Qui-Quadrado , Inibidores de Ciclo-Oxigenase/uso terapêutico , Feminino , Humanos , Masculino , Piroxicam/análogos & derivados , Piroxicam/uso terapêutico , Gravidez , Resultado da Gravidez , Taxa de Gravidez , Contagem de Espermatozoides , Injeções de Esperma Intracitoplásmicas , Motilidade dos Espermatozoides , Estatísticas não Paramétricas , Complexo Vitamínico B/uso terapêutico
16.
Fertil Steril ; 97(5): 1067-1073.e1, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22386843

RESUMO

OBJECTIVE: To evaluate the effects on human spermatozoa of freeze-drying, also known as lyophilization, and of cryopreservation in liquid nitrogen. DESIGN: Prospective experimental study. SETTING: Reproductive medicine unit and a private IVF center. PATIENT(S): Thirty healthy male donors. INTERVENTION(S): Sperm samples from 30 donors divided as two aliquots, one to be lyophilized and the other to be cryopreserved in liquid nitrogen. MAIN OUTCOME MEASURE(S): Assessment of count, motility, morphology, viability, DNA integrity, chromosomal status, and birefringence properties of lyophilized and cryopreserved human spermatozoa compared with the same parameters in the fresh sample. RESULT(S): Although sperm viability and motility were totally compromised after freeze-drying, the sperm chromatin structure was not altered in comparison with fresh samples, which demonstrated that the procedure did not affect DNA integrity. The sperm-head inner protoplasmic structures were also preserved, which was estimated by assessing the corresponding birefringence characteristics. After cryopreservation with liquid nitrogen, the motility, viability, and DNA integrity of spermatozoa were statistically significantly reduced compared with the fresh samples; the proportion of sperm cells with abnormal head birefringence increased meaningfully. CONCLUSION(S): The process of freeze-drying deeply damages cell membranes; however, unlike with liquid nitrogen preservation, it does not affect DNA integrity.


Assuntos
Montagem e Desmontagem da Cromatina , Criopreservação/métodos , Dano ao DNA , Liofilização , Nitrogênio , Espermatozoides/patologia , Adulto , Aneuploidia , Birrefringência , Membrana Celular/patologia , Sobrevivência Celular , Humanos , Hibridização in Situ Fluorescente , Masculino , Nitrogênio/efeitos adversos , Estudos Prospectivos , Contagem de Espermatozoides , Motilidade dos Espermatozoides
17.
Reprod Biomed Online ; 20(2): 261-6, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20113964

RESUMO

Cross-border reproductive care, also called reproductive tourism, refers to the travelling of citizens from their country of residence to another country in order to receive fertility treatment through assisted reproductive technology. Several reasons account for cross-border reproductive care: (i) a certain kind of treatment is forbidden by law in the couple's own country or is inaccessible to the couple because of their demographic or social characteristics; (ii) foreign centres report higher success rates compared with those of the centres in the country of residence; (iii) a specific treatment may be locally unavailable because of a lack of expertise or because the treatment is considered experimental or insufficiently safe; and (iv) limited access to the treatment in the couple's home country because of long waiting lists, excessive distance from a centre or high costs. Although cross-border reproductive care can be viewed as a safety valve, the phenomenon is often associated with a high risk of health dangers, frustration and disparities. Solutions to these problematic effects need to be considered in the light of the fact that cross-border reproductive care is a growing phenomenon.


Assuntos
Turismo Médico/ética , Técnicas de Reprodução Assistida , Feminino , Humanos , Infertilidade/terapia , Masculino , Turismo Médico/legislação & jurisprudência , Turismo Médico/psicologia
18.
Biol Reprod ; 79(4): 667-73, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18562708

RESUMO

Interdependence between sperm concentration, motility, morphology, and the percentage of aneuploid sperm was explored to test whether oligoasthenoteratospermia (OAT) may have a multiple origin in idiopathic infertile males. A total of 174 men (age, 35.8 +/- 4.3 yr) with idiopathic infertility were studied. Seven patients had nonobstructive azoospermia, 55 had severe OAT, 30 had OAT, 27 had isolated alterations of motility, 45 had alterations of morphology and of motility, and 10 had isolated alterations of morphology. The sperm morphology was assessed with strict criteria. The percentage of aneuploid sperm was assessed with fluorescent in situ hybridization for chromosomes X, Y, 13, 15, 16, 17, 18, 21, and 22. Relationships between sperm features, and the relationship between sperm features and aneuploidies were analyzed with multivariate regression analysis. Statistical analysis did not find any significant relationship between the percentage of typical forms and sperm concentration or between morphology and motility. On the other hand, a positive and significant relationship was found between sperm concentration and motility. The percentage of aneuploid sperm was inversely and significantly related to the percentage of typical forms but not to motility and concentration. Sperm morphology is an independent characteristic with respect to concentration and motility, whereas it showed a significant inverse relationship with respect to the percentage of aneuploid sperm. This means that idiopathic OAT may occur by means of at least two independent pathways, the first affecting concentration and/or motility and the second affecting morphology.


Assuntos
Astenozoospermia/complicações , Genes Controladores do Desenvolvimento/fisiologia , Infertilidade Masculina/genética , Oligospermia/complicações , Adulto , Aneuploidia , Azoospermia/genética , Análise Citogenética , Humanos , Infertilidade Masculina/etiologia , Masculino , Contagem de Espermatozoides , Motilidade dos Espermatozoides/genética
19.
Fertil Steril ; 87(3): 534-41, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17123520

RESUMO

OBJECTIVE: To analyze embryo morphology in relation to the corresponding chromosomal status, in order to evaluate the effects of aneuploidy over fragmentation, delayed cleavage, and arrested cleavage. DESIGN: Retrospective study. SETTING: Reproductive Medicine Unit, Società Italiana di Studi di Medicina della Riproduzione, Bologna, Italy. PATIENT(S): A total of 662 patients with a poor prognosis for pregnancy underwent 916 cycles of preimplantation genetic diagnosis for aneuploidy. INTERVENTION(S): The chromosomes XY, 13, 15, 16, 18, 21, and 22 were analyzed in blastomeres biopsied from day 3 embryos. MAIN OUTCOME MEASURE(S): Embryo morphology, chromosomal status of the analyzed blastomeres, and spreading and reanalysis of nontransferred embryos. RESULT(S): The incidence of chromosomal abnormalities was significantly higher in arrested or slow-cleaving embryos, and in embryos cleaving too fast, compared to embryos with eight cells at 62 hours after insemination. The presence of an uneven number of blastomeres or fragments scattered in the perivitelline space was associated with an increased incidence of chromosomal abnormalities. CONCLUSION(S): A correlation between embryo development and chromosomal complement makes the incidence of chromosomal abnormalities significantly higher in embryos dividing according to a time frame and a symmetry plan which are different from what are expected. The type of fragmentation is also related to chromosomal status, which explains why the extrusion of fragments might severely affect embryo viability.


Assuntos
Embrião de Mamíferos/anatomia & histologia , Desenvolvimento Embrionário/genética , Diagnóstico Pré-Implantação , Adulto , Aneuploidia , Biópsia , Aberrações Cromossômicas , Cromossomos Humanos Par 13/genética , Cromossomos Humanos Par 15/genética , Cromossomos Humanos Par 16/genética , Cromossomos Humanos Par 18/genética , Cromossomos Humanos Par 21/genética , Cromossomos Humanos Par 22/genética , Cromossomos Humanos X/genética , Cromossomos Humanos Y/genética , Feminino , Fertilização in vitro , Humanos , Hibridização in Situ Fluorescente , Gravidez , Estudos Retrospectivos , Aberrações dos Cromossomos Sexuais
20.
Hum Reprod ; 21(10): 2482-5, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16740525

RESUMO

The article presents a new system for the recruitment of gamete donors. The system is a partial application of the mirror exchange system: the male partner of a couple donates sperm, and in return, he receives the guarantee that his partner benefits from a greatly reduced waiting time for donor oocytes. More specifically, the woman will obtain donor oocytes within a period of 8 months. The procedure was very successful in recruiting sperm donors while avoiding the ethical objections raised against other incentives to attract donors. The data indicate that the system would also work to encourage IVF patients to share their oocytes.


Assuntos
Doação de Oócitos/estatística & dados numéricos , Doadores de Tecidos/provisão & distribuição , Adulto , Feminino , Fertilização in vitro/normas , Humanos , Masculino , Ciclo Menstrual , Pessoa de Meia-Idade , Seleção de Pacientes , Doadores de Tecidos/estatística & dados numéricos , Listas de Espera
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...